vs
CareDx, Inc.（CDNA）与DOMO, INC.（DOMO）财务数据对比。点击上方公司名可切换其他公司
CareDx, Inc.的季度营收约是DOMO, INC.的1.5倍（$117.7M vs $79.4M），CareDx, Inc.净利率更高（2.4% vs -13.1%，领先15.5%），CareDx, Inc.同比增速更快（39.0% vs -0.5%），DOMO, INC.自由现金流更多（$1.1M vs $514.0K），过去两年CareDx, Inc.的营收复合增速更高（12.9% vs -0.5%）
CareDx是一家专注于器官移植领域的精准医疗企业，核心产品包括移植排斥反应监测诊断试剂、数字健康管理工具及配套临床服务，面向北美和欧洲市场的医疗机构及移植患者，助力提升术后患者生存质量。
Domo股份有限公司是总部设在美国犹他州美国福克的美国云软件企业，主营人工智能、商业智能与数据可视化业务，属于SaaS（软件即服务）企业，核心产品可帮助企业各层级决策者在极少IT介入的情况下，实时获取业务数据，支撑决策开展。
CDNA vs DOMO — 直观对比
营收规模更大
CDNA
是对方的1.5倍
$79.4M
营收增速更快
CDNA
高出39.4%
-0.5%
净利率更高
CDNA
高出15.5%
-13.1%
自由现金流更多
DOMO
多$578.0K
$514.0K
两年增速更快
CDNA
近两年复合增速
-0.5%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $117.7M | $79.4M |
| 净利润 | $2.8M | $-10.4M |
| 毛利率 | — | 74.2% |
| 营业利润率 | 1.0% | -8.7% |
| 净利率 | 2.4% | -13.1% |
| 营收同比 | 39.0% | -0.5% |
| 净利润同比 | — | 44.6% |
| 每股收益（稀释后） | $0.05 | $-0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDNADOMO
| Q1 26 | $117.7M | — | ||
| Q4 25 | $108.4M | $79.4M | ||
| Q3 25 | $100.1M | $79.7M | ||
| Q2 25 | $86.7M | $80.1M | ||
| Q1 25 | $84.7M | $78.8M | ||
| Q4 24 | $86.6M | $79.8M | ||
| Q3 24 | $82.9M | $78.4M | ||
| Q2 24 | $92.3M | $80.1M |
净利润CDNADOMO
| Q1 26 | $2.8M | — | ||
| Q4 25 | $-4.1M | $-10.4M | ||
| Q3 25 | $1.7M | $-22.9M | ||
| Q2 25 | $-8.6M | $-18.1M | ||
| Q1 25 | $-10.4M | $-17.7M | ||
| Q4 24 | $87.7M | $-18.8M | ||
| Q3 24 | $-10.6M | $-19.5M | ||
| Q2 24 | $-4.6M | $-26.0M |
毛利率CDNADOMO
| Q1 26 | — | — | ||
| Q4 25 | — | 74.2% | ||
| Q3 25 | — | 74.8% | ||
| Q2 25 | — | 74.2% | ||
| Q1 25 | — | 74.4% | ||
| Q4 24 | — | 75.0% | ||
| Q3 24 | — | 74.3% | ||
| Q2 24 | — | 74.1% |
营业利润率CDNADOMO
| Q1 26 | 1.0% | — | ||
| Q4 25 | -5.6% | -8.7% | ||
| Q3 25 | -0.2% | -9.1% | ||
| Q2 25 | -12.8% | -17.9% | ||
| Q1 25 | -15.8% | -15.6% | ||
| Q4 24 | 97.5% | -13.9% | ||
| Q3 24 | -16.6% | -18.5% | ||
| Q2 24 | -7.9% | -26.8% |
净利率CDNADOMO
| Q1 26 | 2.4% | — | ||
| Q4 25 | -3.8% | -13.1% | ||
| Q3 25 | 1.7% | -28.8% | ||
| Q2 25 | -9.9% | -22.5% | ||
| Q1 25 | -12.2% | -22.4% | ||
| Q4 24 | 101.3% | -23.5% | ||
| Q3 24 | -12.8% | -24.9% | ||
| Q2 24 | -5.0% | -32.5% |
每股收益（稀释后）CDNADOMO
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-0.08 | $-0.25 | ||
| Q3 25 | $0.03 | $-0.56 | ||
| Q2 25 | $-0.16 | $-0.45 | ||
| Q1 25 | $-0.19 | $-0.45 | ||
| Q4 24 | $1.60 | $-0.48 | ||
| Q3 24 | $-0.20 | $-0.51 | ||
| Q2 24 | $-0.09 | $-0.69 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $77.9M | — |
| 总债务越低越好 | — | $124.2M |
| 股东权益账面价值 | — | $-191.9M |
| 总资产 | $411.1M | $201.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CDNADOMO
| Q1 26 | $77.9M | — | ||
| Q4 25 | $177.2M | — | ||
| Q3 25 | $194.2M | — | ||
| Q2 25 | $186.3M | $47.2M | ||
| Q1 25 | $230.9M | $45.3M | ||
| Q4 24 | $260.7M | — | ||
| Q3 24 | $240.9M | — | ||
| Q2 24 | $228.9M | $61.2M |
总债务CDNADOMO
| Q1 26 | — | — | ||
| Q4 25 | — | $124.2M | ||
| Q3 25 | — | $121.9M | ||
| Q2 25 | — | $119.7M | ||
| Q1 25 | — | $117.7M | ||
| Q4 24 | — | $115.6M | ||
| Q3 24 | $0 | $115.2M | ||
| Q2 24 | $0 | $114.1M |
股东权益CDNADOMO
| Q1 26 | — | — | ||
| Q4 25 | $303.1M | $-191.9M | ||
| Q3 25 | $311.1M | $-191.5M | ||
| Q2 25 | $327.4M | $-178.7M | ||
| Q1 25 | $379.3M | $-177.2M | ||
| Q4 24 | $378.4M | $-171.2M | ||
| Q3 24 | $273.2M | $-166.4M | ||
| Q2 24 | $264.7M | $-163.5M |
总资产CDNADOMO
| Q1 26 | $411.1M | — | ||
| Q4 25 | $413.2M | $201.6M | ||
| Q3 25 | $432.3M | $195.7M | ||
| Q2 25 | $444.3M | $189.7M | ||
| Q1 25 | $489.6M | $214.3M | ||
| Q4 24 | $491.1M | $190.2M | ||
| Q3 24 | $477.0M | $197.8M | ||
| Q2 24 | $466.8M | $204.4M |
负债/权益比CDNADOMO
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.3M | $3.4M |
| 自由现金流经营现金流 - 资本支出 | $514.0K | $1.1M |
| 自由现金流率自由现金流/营收 | 0.4% | 1.4% |
| 资本支出强度资本支出/营收 | — | 2.9% |
| 现金转化率经营现金流/净利润 | 1.54× | — |
| 过去12个月自由现金流最近4个季度 | — | $9.9M |
8季度趋势，按日历期对齐
经营现金流CDNADOMO
| Q1 26 | $4.3M | — | ||
| Q4 25 | $21.4M | $3.4M | ||
| Q3 25 | $37.4M | $3.4M | ||
| Q2 25 | $9.9M | $4.0M | ||
| Q1 25 | $-26.6M | $8.9M | ||
| Q4 24 | $21.9M | $-13.7M | ||
| Q3 24 | $12.5M | $-6.2M | ||
| Q2 24 | $18.9M | $1.9M |
自由现金流CDNADOMO
| Q1 26 | $514.0K | — | ||
| Q4 25 | — | $1.1M | ||
| Q3 25 | — | $1.0M | ||
| Q2 25 | — | $1.0M | ||
| Q1 25 | — | $6.7M | ||
| Q4 24 | — | $-16.2M | ||
| Q3 24 | — | $-8.4M | ||
| Q2 24 | — | $-625.0K |
自由现金流率CDNADOMO
| Q1 26 | 0.4% | — | ||
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 1.3% | ||
| Q1 25 | — | 8.5% | ||
| Q4 24 | — | -20.3% | ||
| Q3 24 | — | -10.7% | ||
| Q2 24 | — | -0.8% |
资本支出强度CDNADOMO
| Q1 26 | — | — | ||
| Q4 25 | — | 2.9% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | 2.8% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | 3.2% |
现金转化率CDNADOMO
| Q1 26 | 1.54× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 22.30× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.25× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CDNA
| Financial Results Total | $85.0M | 72% |
| Patient and digital solutions revenue | $16.0M | 14% |
| Product revenue | $10.3M | 9% |
| Other | $6.4M | 5% |
DOMO
| Subscription | $71.9M | 91% |
| Professional Servicesand Other | $7.5M | 9% |
